News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|April 5, 2022

Dr. Amy Paller discusses long-term safety and efficacy of ixekizumab in kids

Author(s)Miranda Hester

Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Dr. Paller discusses the findings of the clinical trial discussing the long-term effects of ixekizumab for treating psoriasis in children.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

ByMorgan Ebert, Executive Editor

July 24th 2026

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD | Image credit: © Ruslan Ivantsov - stock.adobe.com.

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD

ByMorgan Ebert, Executive Editor

July 24th 2026

Udenafil study shows lower ELF scores in Fontan-associated liver disease | Image credit: © PIC4U - PIC4U

Udenafil study shows lower ELF scores in Fontan-associated liver disease

ByMorgan Ebert, Executive Editor

July 16th 2026

Trisha Torga, MD, urges pediatricians to address social media skincare trends with adolescents

Trisha Torga, MD, urges pediatricians to address social media skincare trends with adolescents

ByTrisha Torga, MD

July 15th 2026

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

ByKeisha L. Gibson, MD, MPH

July 14th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

Ultra-processed foods tied to brain differences in young children

US measles cases surpass 2025 total, hit highest level since 1991

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD

Text-message video intervention does not improve infant safe sleep practices in low-income families